Rational Modification of Oncolytic Viruses Using small RNAs

Oncolytic Adenoviruses: Selecting and Engineering Adenovirus Serotypes with Improved Oncolytic and Immunostimulatory Potency

Mathematical Modeling of Combined Oncolytic Immunotherapy

Heterotypic Spheroid Model Development for Preclinical Studies of Virotherapy-induced Changes of Tumor Microenvironment

RadioViroTherapy for Treatment of Refractory Solid Cancer

Viro-antibody therapy: Engineering oncolytic adenoviruses for genetic delivery of therapeutic antibodies

Boosting oncolytic viruses by small molecule compounds

RNA switch-inducible genetic delivery of biotherapeutics by oncolytic viruses

Oncolytic neoepitope-vaccine therapy for treatment of solid cancer